HF Kung

472 total citations
11 papers, 407 citations indexed

About

HF Kung is a scholar working on Molecular Biology, Biotechnology and Immunology. According to data from OpenAlex, HF Kung has authored 11 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Biotechnology and 3 papers in Immunology. Recurrent topics in HF Kung's work include Virus-based gene therapy research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and HIV Research and Treatment (1 paper). HF Kung is often cited by papers focused on Virus-based gene therapy research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and HIV Research and Treatment (1 paper). HF Kung collaborates with scholars based in United States, Hong Kong and China. HF Kung's co-authors include Atsushi Suzuki, Naoto Ueno, LI Zon, Clair Kelley, Mitsugu Maéno, Mei-Yi Lin, K.D.K. Luk, J. C. Y. Leong, Rui‐Hua Xu and William W. Lu and has published in prestigious journals such as The Journal of Cell Biology, Blood and International Journal of Cancer.

In The Last Decade

HF Kung

10 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
HF Kung United States 7 292 76 64 50 50 11 407
Keizo Kato Japan 10 212 0.7× 41 0.5× 16 0.3× 69 1.4× 53 1.1× 13 403
Adriana Haimovitz Israel 7 164 0.6× 63 0.8× 60 0.9× 44 0.9× 32 0.6× 11 395
C. L. Brunet United Kingdom 8 322 1.1× 48 0.6× 149 2.3× 13 0.3× 39 0.8× 11 441
Sherri G. Osborn United States 7 154 0.5× 26 0.3× 24 0.4× 34 0.7× 51 1.0× 7 337
Helicia Paz United States 10 308 1.1× 84 1.1× 45 0.7× 20 0.4× 41 0.8× 12 463
I Junghahn Germany 11 211 0.7× 30 0.4× 42 0.7× 48 1.0× 82 1.6× 23 450
U Jäger Germany 8 163 0.6× 25 0.3× 87 1.4× 63 1.3× 59 1.2× 12 448
Marc Padrines France 10 231 0.8× 48 0.6× 27 0.4× 36 0.7× 48 1.0× 15 520
F A Spring United Kingdom 8 331 1.1× 276 3.6× 39 0.6× 35 0.7× 124 2.5× 10 666
Nassima Benzoubir France 9 155 0.5× 39 0.5× 19 0.3× 29 0.6× 27 0.5× 16 353

Countries citing papers authored by HF Kung

Since Specialization
Citations

This map shows the geographic impact of HF Kung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HF Kung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HF Kung more than expected).

Fields of papers citing papers by HF Kung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HF Kung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HF Kung. The network helps show where HF Kung may publish in the future.

Co-authorship network of co-authors of HF Kung

This figure shows the co-authorship network connecting the top 25 collaborators of HF Kung. A scholar is included among the top collaborators of HF Kung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HF Kung. HF Kung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Liang, Yi, Jin Zhao, Jian Lü, et al.. (2015). Differential gene expression profile of CD4+/CD8+ T cells in patients with hepatitis C virus and/or human immunodeficiency virus infection.. PubMed. 21 Suppl 7. S11–3.
2.
Ng, Samuel S., David Chau, Hong Yao, et al.. (2008). Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy. Cancer Gene Therapy. 15(11). 723–732. 14 indexed citations
3.
Chan, CY, et al.. (2008). The aqueous extract of Fructus Ligustri Lucidi regulates the differentiation of mesenchymal stem cells. The HKU Scholars Hub (University of Hong Kong). 4 indexed citations
4.
Luk, K.D.K., Kmc Cheung, Rui‐Hua Xu, et al.. (2003). Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Gene Therapy. 10(16). 1345–1353. 83 indexed citations
5.
Kung, HF, et al.. (2001). Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. International Journal of Cancer. 93(6). 916–916. 17 indexed citations
6.
Maéno, Mitsugu, Clair Kelley, HF Kung, et al.. (1996). The role of BMP-4 and GATA-2 in the induction and differentiation of hematopoietic mesoderm in Xenopus laevis. Blood. 88(6). 1965–1972. 159 indexed citations
7.
X, Liu, et al.. (1994). Emergence of antigenic variants of simian immunodeficiency virus (SIVmac) in a seronegative macaque after SIVmac239 infection.. PubMed. 40(7-8). 661–9. 6 indexed citations
8.
Rybak, S.M., Jing‐Jer Lin, HF Kung, et al.. (1994). IN-VITRO ANTITUMOR-ACTIVITY OF THE PLANT RIBOSOME-INACTIVATING PROTEINS MAP-30 AND GAP-31. International Journal of Oncology. 5(5). 1171–6. 12 indexed citations
9.
Kovács, Gyula, M. Kiechle‐Schwarz, Gerd Scherer, & HF Kung. (1992). Molecular analysis of the chromosome 11p region in renal cell carcinomas.. PubMed. 38(1). 59–62. 3 indexed citations
10.
Kung, HF, et al.. (1992). Regulation of intracellular actin polymerization by prenylated cellular proteins. The Journal of Cell Biology. 117(2). 347–356. 106 indexed citations
11.
Staehelin, T., Jörg Schmidt, B. Takács, et al.. (1983). Monoclonal antibodies to human leukocyte interferons: their use in assay and purification.. PubMed. 41. 43–58. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026